Searched for
PHARMACEUTICAL REGULATION
Govt plans instant ban on manufacturing of drugs failing key quality testsPharma companies could have their drug licenses suspended immediately if quality tests indicate failure. The health ministry's proposed cha...- NPPA updates list of reduced MRP of 1,085 anti-cancer drugsThe National Pharmaceutical Pricing Authority updated the maximum retail price for 1,085 anti-cancer medicines. This revision follows a pre...
- Wockhardt seeks 14-year data shield for India-made drugsMumbai-based Wockhardt has struck success in its innovative research on a range of antibiotic drugs, bridging a global pipeline gap for dif...
- Stop the price scam in our hospitalsA recent investigation in Maharashtra has shed light on concerning price hikes for medical supplies charged to patients. Items such as IV i...
- Why is the US stock market split as Americans vote in the 2026 midterm elections today? Dow falls as S&P 500 and Nasdaq rise; Apple, Nvidia, and AMD in focus - gold and silver dipUS stock market today: US stocks opened mixed on Tuesday as Americans voted in the midterm elections. Investors are also waiting for AMD’s ...
- Cancer drug prices fell in 2019 too, but mark-ups of up to 700% are backThe government's latest cancer drug price cuts may offer patients some relief, but the impact could be short-lived. An analysis of medicine...
- India wants more factories, fabs and data centres. Where will the water come from?India's ambition to become a developed nation by 2047 is constrained by growing water resource challenges. Industries across sectors, inclu...
- Stocks in news: ITC, Marico, SBI, Yatra Online, NSE, Container Corp and Sun PharmaIndian equity benchmarks experienced gains, with Nifty nearing the 23,500 resistance level and strong corporate earnings reported. ITC face...
- Maharashtra FDA suspends 19 food licences; acts against Patanjali distributor over 'adulteration'In a recent operation, the Maharashtra FDA suspended licenses of 19 food business operators for violations. They seized food articles worth...
- Sun Pharma ordered to halt eye drug production at Assam plant over quality lapses: ReportIndian regulators have ordered Sun Pharmaceutical Industries to stop manufacturing ophthalmic products at the Assam facility. This decision...
- India’s drug pricing policy must balance affordability, medicine availability and pharma industry growthThe Government of India has recently capped trade margins on anti-cancer medicines at 30%. This decision has reignited the ongoing discussi...
- These large-, mid- and small-cap stocks can give more than 20% return in 1 year, according to analystsHere’s one thing that is worth clarifying, because it is in the headlines. Large global technology companies have been announcing heavy spe...
- Cancer drug price cuts leave costly brands untouchedPrices of several anti-cancer drugs are set to fall significantly starting November 9, offering some financial relief. However, the prices ...
- India to remain strict on quality: Industry minister Piyush GoyalIndia's Commerce Minister Piyush Goyal emphasised a strict stance on quality and environmental regulations. He noted that many companies ar...
- Indian pharma: Unethical practices, marketing rules under lens; new review body set upThe review comes against the backdrop of the Uniform Code for Pharmaceutical Marketing Practices (UCPMP), which was introduced in 2015 as a...
- From nasal delivery to sterile injectables: Biodeal Pharmaceuticals’ expansion plansBiodeal Pharmaceuticals is set to broaden its horizons with a state-of-the-art sterile injectables plant in Himachal Pradesh. This venture ...
- Cipla subsidiary clears USFDA inspection with zero observationsCipla on Friday said a routine US Food and Drug Administration (USFDA) inspection at its wholly owned subsidiary InvaGen Pharmaceuticals' m...
- GDHS 2026 to focus on implementing AI actionScheduled for 20-21 November 2026, the Global Digital Health Summit will take place in New Delhi, highlighting the role of artificial intel...
- Europe’s last penicillin plant faces a bitter fight against China’s cheaper drugsThe Sandoz penicillin plant in Kundl, Austria, is under threat from cheaper Chinese antibiotic production. European healthcare programs ben...
- Sanofi healthcare receives CDSCO approval for Qftilia therapy for haemophilia patients in IndiaSanofi Healthcare has obtained authorisation from the Central Drugs Standard Control Organisation for Qfitlia. This therapy is designed to ...
Load More
